Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07498153 · ClinicalTrials.gov registry record · NA
Spotting Syphilis: A Dual Point-of-Care Syphilis Screening Initiative in a Low-Resource Healthcare Setting
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 149
- Enrollment target
NCT07498153 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 149 participants.
The verdict
NCT07498153, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 149 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a strategy utilizing the Chembio HIV/syphilis rapid point-of-care (POC) test for diagnosis of HIV and syphilis in pregnant women attending prenatal clinics in Guatemala will increase screening and detection rates thereby resulting in higher rates of treatment during pregnancy and ultimately reducing congenital syphilis and HIV Mother-to-child transmission (MTCT) and to provide knowledge and technical expertise on the use of Point-of-care ultrasound for all pregnant patients testing positive for syphilis during the intervention to evaluate the fetus for evidence of congenital syphilis.
Interventions
- DEVICE Chembio HIV/Syphilis rapid POC test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2025-09-30 |
| Est. Completion | 2025-10-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07498153
The ClinicalTrials.gov registry entry for NCT07498153 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chembio HIV/Syphilis rapid POC test is the first listed.
NCT07498153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07498153 about?
NCT07498153 is a clinical study titled "Spotting Syphilis: A Dual Point-of-Care Syphilis Screening Initiative in a Low-Resource Healthcare Setting". The purpose of this study is to determine if a strategy utilizing the Chembio HIV/syphilis rapid point-of-care (POC) test for diagnosis of HIV and syphilis in pregnant women attending prenatal clinics in Guatemala will increase screening and detection rates thereby resulting in higher rates of treat...
What is the current status of trial NCT07498153?
This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2025-09-30. Estimated completion is 2025-10-02.
What interventions are being tested in trial NCT07498153?
The interventions under investigation include: Chembio HIV/Syphilis rapid POC test (DEVICE).
Who is sponsoring clinical trial NCT07498153?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.